查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1526347

全球數位療法市場

Digital Therapeutics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 326 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球數位治療市場預計將達到 329 億美元

全球數位治療市場預計 2023 年為 57 億美元，預計到 2030 年將達到 329 億美元，2023-2030 年分析期間複合年成長率為 28.6%。治療/護理應用是本報告分析的細分市場之一，預計複合年成長率為 29.1%，到分析期結束時將達到 281 億美元。分析期內，預防性應用領域的複合年成長率預計為 26.0%。

美國市場預計23億美元，中國預計複合年成長率32.2%

預計 2023 年美國數位治療市場價值將達到 23 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達32億美元，2023-2030年分析期間複合年成長率為32.2%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 25.4% 和 23.6%。在歐洲，德國預計複合年成長率為 28.5%。

全球數位治療市場 - 主要趨勢和促進因素總結

數位治療 (DTx) 是醫療保健行業的一個變革部分，專注於透過軟體程式提供基於證據的治療性介入，以預防、管理和治療醫療狀況。這些治療性介入通常透過行動應用程式、數位設備和線上平台提供，旨在與傳統治療一起或單獨使用。數位治療利用行為科學、人工智慧和資料分析來提供個人化治療計劃、即時監測患者進展並提供回饋以改善健康結果。臨床檢驗是數位療法的基石，確保這些解決方案符合與傳統藥物相當的嚴格的功效和安全標準。

數位療法可治療多種疾病，包括糖尿病和高血壓等慢性疾病，以及焦慮和憂鬱症等精神疾病。透過將數位工具整合到傳統醫療保健中，DTx 解決方案可以提供持續監測和即時干預措施，這對於有效管理慢性病至關重要。這些解決方案還使患者能夠更好地控制自己的健康，從而提高患者的參與度並提高對治療計劃的依從性。此外，數位療法可以彌合獲得醫療保健的差距，並透過可擴展、經濟高效且易於訪問的數位平台為服務不足的人群提供支援。遊戲化和使用者友善介面的結合進一步提高了患者的參與度和依從性，使個人更容易遵守治療計劃。

數位治療市場的成長受到多種因素的推動。數位療法主要是由慢性病盛行率不斷上升和個人化醫療需求不斷增加所推動的，因為它提供了量身定做的干涉措施，可以顯著改善患者的治療效果。人工智慧、機器學習和行動醫療技術的進步正在增強 DTx 解決方案的功能和範圍，使其更加有效和方便用戶使用。消費行為也是一個關鍵促進因素，患者越來越習慣使用數位健康工具並尋求主動的健康管理。醫療保健提供者和保險公司對數位療法的監管支持和認可證明了 DTx 解決方案的有效性和可靠性，進一步推動了市場的發展。此外，COVID-19 大流行加速了數位醫療技術的採用，凸顯了遠距醫療解決方案的重要性，並增加了對數位治療領域的投資。總的來說，這些因素促進了醫療保健領域數位療法的強勁成長和更多採用。

受訪企業範例（共136家）

  • Aptar Digital Health
  • Better Therapeutics, Inc
  • Biofourmis Inc.
  • Canary Health, Inc.
  • Click Therapeutics, Inc.
  • Fitbit Health Solutions
  • Pear Therapeutics, Inc.
  • Wellthy Therapeutics Pvt Ltd

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 比賽

簡介目錄
Product Code: MCP11567

Global Digital Therapeutics Market to Reach US$32.9 Billion by 2030

The global market for Digital Therapeutics estimated at US$5.7 Billion in the year 2023, is expected to reach US$32.9 Billion by 2030, growing at a CAGR of 28.6% over the analysis period 2023-2030. Treatment / Care Application, one of the segments analyzed in the report, is expected to record a 29.1% CAGR and reach US$28.1 Billion by the end of the analysis period. Growth in the Preventive Application segment is estimated at 26.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 32.2% CAGR

The Digital Therapeutics market in the U.S. is estimated at US$2.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 32.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 25.4% and 23.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 28.5% CAGR.

Global Digital Therapeutics Market - Key Trends & Drivers Summarized

Digital Therapeutics (DTx) represents a transformative segment of the healthcare industry, focusing on delivering evidence-based therapeutic interventions through software programs to prevent, manage, or treat medical conditions. These interventions are often delivered via mobile apps, digital devices, and online platforms, and are designed to be used independently or alongside traditional medical treatments. Digital therapeutics leverage behavioral science, artificial intelligence, and data analytics to provide personalized treatment plans, monitor patient progress in real-time, and offer feedback to improve health outcomes. Clinical validation is a cornerstone of digital therapeutics, ensuring that these solutions meet rigorous standards of efficacy and safety comparable to traditional pharmaceuticals.

Digital therapeutics address a wide range of conditions, including chronic diseases like diabetes, hypertension, and mental health disorders such as anxiety and depression. By integrating digital tools with traditional healthcare, DTx solutions can offer continuous monitoring and real-time interventions, which are crucial for managing chronic diseases effectively. These solutions also empower patients by giving them greater control over their health, enhancing engagement and adherence to treatment plans. Additionally, digital therapeutics can bridge gaps in healthcare access, providing support to underserved populations through scalable, cost-effective, and easily accessible digital platforms. The incorporation of gamification and user-friendly interfaces further enhances patient engagement and compliance, making it easier for individuals to stick to their therapeutic regimens.

The growth in the digital therapeutics market is driven by several factors. The increasing prevalence of chronic diseases and the rising demand for personalized medicine are primary drivers, as digital therapeutics offer tailored interventions that can significantly improve patient outcomes. Technological advancements in AI, machine learning, and mobile health technologies are enhancing the capabilities and reach of DTx solutions, making them more effective and user-friendly. Consumer behavior is also a significant driver, with patients becoming more comfortable using digital health tools and seeking proactive management of their health. Regulatory support and the recognition of digital therapeutics by healthcare providers and insurers are further propelling the market, as these endorsements validate the efficacy and reliability of DTx solutions. Additionally, the COVID-19 pandemic has accelerated the adoption of digital health technologies, highlighting the importance of remote healthcare solutions and increasing investment in the digital therapeutics sector. These factors collectively contribute to the robust growth and expanding adoption of digital therapeutics in the healthcare landscape.

Select Competitors (Total 136 Featured) -

  • Aptar Digital Health
  • Better Therapeutics, Inc
  • Biofourmis Inc.
  • Canary Health, Inc.
  • Click Therapeutics, Inc.
  • Fitbit Health Solutions
  • Pear Therapeutics, Inc.
  • Wellthy Therapeutics Pvt Ltd

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Digital Therapeutics is Poised to Benefit from the Increasingly Robust Outlook for Digital Health
    • Digital Healthcare Sets the Stage for the Rise of Digital Therapeutics: Global Market for Digital Health (In US$ Billion) for Years 2023, 2025, and 2027
    • Global Economic Update
    • Competition
    • Digital Therapeutics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Digital Therapeutics: Overview & Market Outlook
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Global Focus on Meeting Unmet Needs in Mental Healthcare to Benefit Growth of Digital Therapeutics
    • Shockingly High Burden of Mental Disorders & the Ensuing Focus to Meet Unmet Care Needs Primes Digital Therapeutics for Mass Adoption: Global Economic Cost of Mental Illnesses (In US$ Trillion) for Years 2023, 2025, 2027, 2029 & 2031
    • Artificial Intelligence to Play a Key Role in Improving the Effectiveness of Digital Therapeutics
    • High Prevalence of Chronic Diseases and Growing Focus Long-Term Management & Preventative Healthcare Widens Growth Opportunities
    • Rising Prevalence of Chronic Diseases Amplifies the Need for Addressing Management of These Diseases Through Digital Therapeutics: Global Cost of Chronic Diseases (In US$ Trillion) for the Years 2023, 2025, 2027, 2029 and 2031
    • Here's How Digital Therapeutics Can Help Improve Clinical Outcomes Across the Cardiac Continuum
    • Global Annual Medical Cost of Cardiovascular Diseases in US$ Billion (2010-2030)
    • How Digital Therapeutics is Changing the Oncology Care Landscape?
    • Worrisome Epidemic Increase in Cancer Incidence to Help Accelerate Adoption of Digital Therapeutics: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Rise of mHealth & Smart Medical Devices & Wearables Paves the Way for More Spontaneous Adoption of Digital Therapeutics
    • Growing Familiarity with mHealth & Use of Medical Wearables Means There is One Less Obstacle in the Implementation of Digital Therapeutics: Global Market for mHealth & Medical Wearables (In US$ Billion) for Years 2023, 2025, 2027, 2029 and 2031
    • As Healthcare Costs Continue to Spiral, Growing Much Faster Than National GDP, Focus Shifts to Digital Therapeutics for its Ability to Lower Cost of Care
    • Growing Urgency to Rein-in Spiraling Healthcare Costs Leads Healthcare Community to Take a Closer Look at Digital Therapeutics: Healthcare Costs as a % of GDP by Country 2020 VS 2023
    • Growing Preference for Personalized Medicine Doubles the Focus on Digital Therapeutics
    • Robust Outlook for Personalized Medicine to Create a Parallel Opportunity for Digital Therapeutics: Global Market for Personalized Medicines (In US$ Billion) for Years 2023 2025, 2027, 2029 and 2031
    • Here's How AR/VR Technologies are Changing the Future of Digital Therapeutics
    • The Many Benefits of 5G in Healthcare to Catalyze Adoption of Digital Therapeutics
    • Rapid Penetration of 5G Will Make Implementation of Digital Therapeutics Seamless & More Efficient to Use: Global 5G Subscription (In Million) for Years 2023, 2025, 2027 and 2029
    • Technology and Innovation to Continue to Drive Adoption of Digital Therapeutics
    • Cybersecurity Storms Into the Spotlight. Here's Why
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Digital Therapeutics Market Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for B2B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for B2B by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for B2C by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for B2C by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Treatment / Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Treatment / Care by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Preventive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Preventive by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 12: USA Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 13: USA 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 14: USA Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • CANADA
    • TABLE 16: Canada Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 17: Canada 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 18: Canada Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Canada 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • JAPAN
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 22: Japan Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: Japan 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • CHINA
    • TABLE 24: China Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: China 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 26: China Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • EUROPE
    • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 28: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: Europe 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 30: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • FRANCE
    • TABLE 34: France Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: France 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 36: France Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: France 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • GERMANY
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 40: Germany Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Germany 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • ITALY
    • TABLE 42: Italy Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Italy 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • UNITED KINGDOM
    • TABLE 46: UK Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: UK 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 48: UK Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: UK 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Rest of Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 54: Asia-Pacific Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Asia-Pacific 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 58: Rest of World Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Rest of World 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
    • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Rest of World 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030

IV. COMPETITION